Advancing excellence in laboratory medicine for better healthcare worldwide

IFCC Task Force on COVID-19

Membership

NamePositionCountryTermTime in Office
Giuseppe LippiChairIT1st2020 03 - 2022 12
Andrea HorvathMemberAU1st2020 03 - 2022 12
David KochMemberUS1st2020 03 - 2022 12
Nicasio ManciniMemberIT1st2020 04 - 2022 12
Sunil SethiMemberSG1st2020 03 - 2022 12
Cheng-Bin WangMemberCN1st2020 04 - 2022 12
KY YuenMemberHK1st2020 04 - 2022 12



Introduction

The leading objectives of this TF encompass the provision of regular updates on epidemiology, pathogenesis and laboratory diagnostics of COVID-19, the development of practical recommendations for harmonizing the use of diagnostic tests for COVID-19 and biosafety measures for managing the specimens, as well as the organization of international studies to improve the knowledge on pathogenesis, diagnostics and therapeutic management of COVID-19.


Terms of reference

  • Establish and maintain an IFCC e-learning platform on COVID-19 (“IFCC Information Guide on COVID-19”), which provides regular updates on epidemiology, pathogenesis and laboratory testing of COVID-19;
  • Provide tentative guidance and consensus documents for harmonizing the use of diagnostic and serological tests for COVID-19;
  • Provide tentative guidance for harmonizing biosafety measures during management of COVID-19 specimens by clinical laboratories;
  • Address clinical, technical and organizational perspectives of laboratory-based and POC testing in COVID-19 patients and provide guidelines/recommendation when feasible;
  • Integrate data on COVID-19 laboratory abnormalities from all over the world, and promoting or coordinating new studies;
  • Evaluate opportunities, risks and safety of using non-conventional biological materials for diagnosing COVID-19;
  • Establish and maintain efficient distance learning channels, with organization of webinars and providence of other informative material;
  • Maintain a repository of scientific articles on laboratory testing for diagnosing, prognosticating and monitoring COVID-19.


For latest updated, visit: IFCC Information Guide on COVID-19 - Monday May 25 updates


Experts Consultants

NameAffiliation
Massimo ClementiUniversity Vita-Salute San Raffaele, Milan (Italy)
William D. RawlinsonThe Prince of Wales Hospital, Randwick (Australia)


Corresponding Members nominated by IFCC Regional Federations

NameRegional Federation
Osama NajjarArab Federation of Clinical Biology (AFCB)
Rajiv ErasmusAfrican Federation of Clinical Chemistry (AFCC)
Gye Cheol KwonAsia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB)
María Elizabeth MenezesLatin-American Confederation of Clinical Biochemistry (COLABIOCLI)


Corresponding Members nominated by IFCC Corporate Members

NameCorporate Members
Robert MuellerABBOTT Diagnostics
Marc LeportierBECKMAN COULTER
Maurizio GramegnaSENTINEL CH
Krishna SinghSIEMENS Healthineers


Chair's Contact

Prof. Giuseppe Lippi
Full Professor of Clinical Biochemistry, University of Verona
Director, Service of Laboratory Medicine, University Hospital of Verona
Secretary of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Executive Editor-in-Chief, Annals of Translational Medicine
Editor in Chief, Journal of Laboratory and Precision Medicine
Associate Editor, Clinical Chemistry and Laboratory Medicine
Associate Editor, Seminars in Thrombosis and Hemostasis
E-mail: giuseppe.lippi@univr.it

 
Website developed by Insoft